Sun Pharma promoter meets Sebi chief to clarify on whistleblower complaint

Dilip Shanghvi clarifies stance on various allegations, claims mala fide campaign against him and firm

Sun Pharmaceutical’s promoter Dilip Shanghvi on Monday met Securities and Exchange Board of India (Sebi) chief Ajay Tyagi, clarifying the firm’s stance on various allegations flagged against him and others in a 172-page whistleblower complaint, said a regulatory source.

Shanghvi also requested the market regulator to look into the roles of certain entities, alleging they had adopted unfair trade practices resulting in Sun’s shares taking a plunge recently.

Sources said Shanghvi raised concerns over a certain foreign brokerage report, which, according to him, had drastically eroded shareholders’ value. Sanghvi told the regulator that some people were running a mala fide campaign against